Mupirocin

Contraindications

CONTRAINDICATIONS This drug is contraindicated in patients with known hypersensitivity to any of the constituents of the product.

Pregnancy & Breastfeeding

Pregnancy Teratogenic Effects Pregnancy category B Reproduction studies have been performed in rats and rabbits with mupirocin administered subcutaneously at doses up to 22 and 43 times, respectively, the human topical dose (approximately 60 mg mupirocin per day) on a mg/m 2 basis and revealed no evidence of harm to the fetus due to mupirocin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.